Effects of oxygen on exercise-induced increase of pulmonary arterial pressure in idiopathic pulmonary fibrosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 25, Issue 2, 2008, Pages 133-139

  Pouwels Fry, S ^a   Pouwels, S ^a   Fournier, C ^a   Duchemin, A ^a   Tillie Leblond, I ^a   Le Tourneau, T ^a   Wallaert, Benoit ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Echocardiography; Exercise; Idiopathic pulmonary fibrosis; Oxygen; Pulmonary hypertension

Indexed keywords

CORTICOSTEROID; GAMMA INTERFERON; OXYGEN;

AGED; ARTICLE; CLINICAL ARTICLE; DOPPLER ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TOLERANCE; FEMALE; FIBROSING ALVEOLITIS; HEART LEFT VENTRICLE CONTRACTION; HEART OUTPUT; HEART RIGHT ATRIUM; HUMAN; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; TRANSTHORACIC ECHOCARDIOGRAPHY; VASOCONSTRICTION;

AGED; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE THERAPY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; MALE; OXYGEN CONSUMPTION; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY WEDGE PRESSURE; VENTRICULAR FUNCTION, RIGHT;

EID: 62549105296     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Meltzer EB, Noble PW. Idiopathic pulmonary fibrosis. Orphanet J Rare Dis 2008 Mar 26; 3: 8. Review.
2. Harari S, Simmoneau G, De Juli E, et al. Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation. J Heart Lung Transplant 1997; 16: 460-3.
3. Nadrous HF, Pellikka PA, Krowka MJ, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005; 128: 2393-9.
4. Lettieri CJ, Nathan SD, Barnett SD et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129: 746-52.
5. Zisman DA, Ross DJ, Belperio JA et al. Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med 2007; 101: 2153-9.
6. Leuchte HH, Neurohr C, Baumgartner R, et al. Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 2004; 170: 360-5.
7. Weitzenblum E, Ehrhart M, Rasaholinjanahary J, Hirth C. Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases. Respiration 1983; 44: 118-27.
8. McGoon M, Gutterman D, Steen V, et al. Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension ACCP. Evidence-Based Clinical Practice Guidelines. Chest 2004; 126: 14S-34S.
9. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
10. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511-22.
11. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-35.
12. Ommen SR, Nishimura RA, Hurrell DG, et al. Assessment of right atrial pressure with 2-dimensional and Doppler echocardiography: a simultaneous catheterization and echocardiographic study. Mayo Clin Proc 2000; 75: 24-9.
13. Nathan SD, Shlobin OA, Barnett SD, et al. Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med 2008; 102 (9): 1305-10.
14. Bossone E, Bodini BD, Mazza A, et al. Pulmonary arterial hypertension: the key role of echocardiography. Chest 2005; 127: 1836-43.
15. Grunig E, Janssen B, Mereles D, et al. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 2000; 102: 1145-50.
16. Himelman RB, Stulbarg M, Kircher B, et al. Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease. Circulation 1989; 79: 863-71.
17. Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003; 167: 735-40.
18. Homma A, Anzueto A, Peters JI et al. Pulmonary artery systolic pressure estimated by echocardiogram vs cardiac catheterization in patients awaiting lung transplantation. J Heart Lung Transplant 2001; 20: 833-9.
19. Himelman RB, Stulbarg MS, Lee E, et al. Noninvasive evaluation of pulmonary artery systolic pressures during dynamic exercise by saline-enhanced Doppler echocardiography. Am Heart J 1990; 119: 685-8.
20. Bossone E, Avelar E, Bach DS, et al. Diagnostic value of resting tricuspid regurgitation velocity and right ventricular ejection flow parameters for the detection of exercise induced pulmonary arterial hypertension. Int J Card Imaging 2000; 16: 429-36.
21. Swanson KD, Uts JP, Krowka MJ. Doppler echocardiography-right heart catheterization relationships in patients with idiopathic pulmonary fibrosis and suspected pulmonary hypertension. Med Sci Monit 2008; 14: 177-82.
22. Hsu VM, Moreyra AE, Wilson AC, et al. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right heart catheterization. J Rheumatol 2008; 35: 458-65.
23. Even P. La respiration. Escourrou P, Lockhart A: Elements de biophysique appliqués à la circulation. In Physiologie humaine, Meyer P. Ed Flammarion Medecine-Science (Paris), 1977: 1019-63.
24. Lama VN, Flaherty KR, Toews GB, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168: 1084-90.
25. Hallstrand TS, Boitano LJ, Johnson WC et al. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J 2005; 25: 96-103
26. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 892-8.
27. Kubo H, Nakayama K, Yanai M, et al. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 2005; 128: 1475-82.
28. Strange C, Highland KB. Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med 2005; 11: 452-5.
29. Bresser P, Fedullo PF, Auger WR, et al. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 23: 595-600.
30. Granath A, Jonsson B, Strandell T. Circulation in healthy old men, studied by right heart catheterization at rest and during exercise in supine and sitting position. Acta Med Scand 1964; 176: 425-46.
31. Chenivesse C, Rachenne V, Fournier C et al. Cardio pulmonary exercise testing in exercise-induced pulmonary hypertension. Rev Mal Respir 2006; 23: 141-8.